Mood Stab

Anti-epileptics
DR. ALTAF QADIR KHAN

PROFESSOR OF PSYCHIATRY
PGMI/LAHORE GENERAL HOSPITAL, LAHORE
Mood Stabilizers
Anti-epileptics
Bromide
Phenobarbitone
Phenytoin
Valproic acid
Carbamazepine
Lamotrigine
Levetracetam
Topiramate
Gabapentin
Pregabalin
Antiepileptics
Carbamazepine (Tegral)
Na Valproate (Epival)
Lamotrigine (Lamictal)
Levetracitam (Lyrica)
Topiramate (Topamax)
Na channels
Neurones fire at high frequencies during seizures
Action potential generation is dependent on Na+ channels
Na+ channel blockers reduce high frequency firing without

affecting physiological firing
Ca channels
Absence seizures are caused by oscillations between thalamus
and cortex that are generated in thalamus by T-type (transient)
Ca2+ currents
Ethosuximide is a specific blocker of T-type currents and is

highly effective in treating absence seizures
K channels
K+ channels have important inhibitory control over neuronal
firing in CNS – repolarize membrane to end action potentials
K+ channels agonists would decrease hyperexcitability in brain
So far the only drug with known actions on K+ channels is Na

valproate
GABA
GABA
Barbiturates
Benzodiazepines
Gabapentin
Levetiracetam
Tiagabine
Topiramate
Valproate
Vigabatrin
Na++
Na Ca2+2+
Ca
Carbamazepine
Ethosuximide
Lamotrigine
Levetiracetam
Oxcarbazepine
Pregabalin
Phenytoin
Valproate
Topiramate
Valproate
Phenobarbital
Partial seizures, effective in neonates
Second-line drug in adults
Modulator of GABA A receptor
Half life 50 – 120 hours
Adverse effects: CNS sedation (excitement) skin rashes
Tolerance and physical dependence possible
Interactions: CNS depression with benzodiazepines
Phenytoin
First line drug for partial seizures
Inhibits Na+ channels
Half life 22 – 36 hours
Adverse affects: CNS sedation, drowsiness, ataxia, confusion,
insomnia, nystagmus, gum hyperplasia, hirsutism
Interactions: carbamazepine decreases and diazepam
increases plasma levels
Benzodiazepines
Diazepam and clonazepam
Status epilepticus
GABA A receptors
Half life: 20 – 40 hours
Adverse effects: CNS sedative, tolerance, dependence
paradoxical hyper-excitability in children
Drug interactions: enhance the action of other CNS
depressants
Carbamazepine (Tegral)
First line agent for acute mania and mania prophylaxis
Indicated for rapid cyclers and mixed patients
Carbamazepine
First-line drug for partial seizures
Inhibits Na+ channels
Half life: CNS sedation. Agranulocytosis and aplastic anemia in
elderly patients, rare but very serious adverse side effect. Mild
transient leukopenia in 10% (usually disappears in first 4
months)
Can exacerbate some generalized seizures
Drug interactions: stimulates the metabolism of other drugs
and stimulates its own metabolism (this may require increase
in dose)
.
Before med is started: baseline liver function tests, CBC and an
EKG
Monitoring: Steady state achieved after 5 days -check 12 hours
after last dose and repeat CBC and LFTs
Goal: Target levels 4-12mcg/ml
Need to check level and adjust dosing after around a month
because induces own metabolism
Carbamazepine side effects
Rash- most common SE seen
Nausea, vomiting, diarrhea, transaminitis
Sedation, dizziness, ataxia, confusion
AV conduction delays
Aplastic anemia and agranulocytosis (<0.002%)
Water retention due to vasopressin-like effect which can result
in hyponatremia
Drug-drug interactions
Valproate
First-line for generalized seizures, partial seizures
Enhances GABA transmission, blocks Na+ channels, activates
K+ channels
Adverse effects: CNS depressant , anorexia nausea, vomiting
hair loss, weight gain, elevation of liver enzymes.
Hepatotoxicity is rare but severe
Drug Interactions: may potentiate CNS depressants
Steven-Johnson syndrome
Valproic acid (Epival)
Valproic acid is as effective as Lithium in mania prophylaxis but
is not as effective in depression prophylaxis
Factors predicting a positive response:
Rapid cycling patients (females>males)
Comorbid substance issues
Mixed patients
Comorbid anxiety disorders
Better tolerated than Lithium
Valproic acid
Before med is started: baseline liver function tests (LFT),
pregnancy test and CBC
Start folic acid supplement in women
Monitoring: Steady state achieved after 4-5 days -check 12
hours after last dose and repeat CBC and Liver Function Tests
Goal: target level is between 50-125
Ethosuximide
Absence seizures
Blocks T-type Ca++ currents in thalamus
Half life: 40 hours
Adverse effects: gastric distress – pain, nausea, vomiting.
Transient fatigue, dizziness, headache
Drug interactions: Valproate inhibits its metabolism
Lamotrigine
Effective against generalized seizures
Mono-therapy for refractory partial seizures
Add-on therapy
Inhibition of Na+ channels, glutamate release , may inhibit Ca+
+ channels
Half life: 24 hours
Adverse effects: CNS sedative (less), Dermatitis
Drug interactions: Valproate increases its level, Carbamazepine
decreases its level
Lamotrigine ( Lamictal)
Indications similar to other anticonvulsants
Also used for neuropathic/chronic pain
Before med is started: baseline liver function tests
Initiation/titration: start with 25 mg daily X 2 weeks then
increase to 50mg X 2 weeks then increase to 100mg- faster
titration has a higher incidence of serious rash
If the patient stops the med for 5 days or more have to start at
25mg again
Levetiracetam
Add-on therapy for partial seizures
Binds to synaptic vesicle protein SV2A, may regulate
neurotransmitter release
Adverse effects: CNS depressant
Drug interactions: minimal
Topiramate
Effective as monotherapy for partial or generalized seizures
Add-on for refractory partial or generalized seizures
Blockade of Na+ channels, increases frequency of GABA A
channel openings, may interfere glutamate binding
Adverse effects: CNS sedative
Drug interactions: some drugs
Antipsychotics as mood
stabilizers
Antipsychotics as mood
stabilizers
Olanzapine
Quetiapine
Lithium
Salt
Soft drinks
Lithium batteries
Greek tradition
Therapeutic salt (Cade)
Mood stabilizer
Lithium
Only medication to reduce suicide rate
Rate of completed suicide in BAD 15%
Effective in long-term prophylaxis of both mania and depressive
episodes in 70+% of BAD I patients
Factors predicting positive response to lithium
Prior long-term response or family member with good
response
Classic pure mania
Mania is followed by depression
Lithium
Dose 400 – 800 mg / day
Serum li level
0.5 – 0.8 mmol/L prophylactic
0.8 – 1.0 mmol/L therapeutic
Toxicity
Hypothyroidism
Cardiac toxicity
Diabetes insipidus
Lithium- how to use it
Before starting :Get baseline creatinine, TSH and CBC. In
women check a pregnancy test- during the first trimester is
associated with Ebstein’s anomaly 1/1000 (20X greater risk
than the general population)
Monitoring: Steady state achieved after 5 days- check 12 hours
after last dose. Once stable check q 3 months and TSH and
creatinine q 6 months.
Goal: blood level between 0.6-1.2
Lithium side effects
Most common are GI distress including reduced appetite,
nausea/vomiting, diarrhea
Thyroid abnormalities
Nonsignificant leukocytosis
Polyuria/polydypsia secondary to ADH antagonism. In a small
number of patients can cause interstitial renal fibrosis.
Hair loss, acne
Reduces seizure threshold, cognitive slowing, intention tremor
Lithium toxicity
Mild- levels 1.5-2.0 see vomiting, diarrhea, ataxia, dizziness,

slurred speech, nystagmus.
Moderate-2.0-2.5 nausea, vomiting, anorexia, blurred vision,

clonic limb movements, convulsions, delirium, syncope
Severe- >2.5 generalized convulsions, oliguria and renal failure

Mood Stab

Uploaded by

Copyright:

Available Formats

Mood Stab

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Mood Stab

Uploaded by

Copyright:

Available Formats

Anti-epileptics

DR. ALTAF QADIR KHAN

Action potential generation is dependent on Na+ channels

Na+ channel blockers reduce high frequency firing without

Ethosuximide is a specific blocker of T-type currents and is

K+ channels agonists would decrease hyperexcitability in brain

So far the only drug with known actions on K+ channels is Na

Mild- levels 1.5-2.0 see vomiting, diarrhea, ataxia, dizziness,

Moderate-2.0-2.5 nausea, vomiting, anorexia, blurred vision,

Severe- >2.5 generalized convulsions, oliguria and renal failure

You might also like